Ex Parte WONG et al - Page 4


                 Appeal No. 2001-1027                                                          Page 4                    
                 Application No. 08/442,210                                                                              

                        “[I]n an ex parte proceeding to obtain a patent, . . . the Patent Office has                     
                 the initial burden of coming forward with some sort of evidence tending to                              
                 disprove novelty.”  In re Wilder, 429 F.2d 447, 450, 166 USPQ 545, 548 (CCPA                            
                 1970).  The standard under § 102 is one of strict identity.  “Under 35 U.S.C.                           
                 § 102, every limitation of a claim must identically appear in a single prior art                        
                 reference for it to anticipate the claim.”  Gechter v. Davidson, 116 F.3d 1454,                         
                 1457, 43 USPQ2d 1030, 1032 (Fed. Cir. 1997).  “Every element of the claimed                             
                 invention must be literally present, arranged as in the claim.”  Richardson v.                          
                 Suzuki Motor Co., Ltd., 868 F.2d 1226, 1236, 9 USPQ2d 1913, 1920 (Fed. Cir.                             
                 1989).                                                                                                  
                        We agree with Appellants that the examiner has not met his burden of                             
                 showing that the products disclosed by Eckenhoff meet all of the limitations of the                     
                 instant claims.  We note that the examiner’s explanation of the rejection does not                      
                 address several limitations of the instant claims.  For example, the examiner                           
                 does not address the requirements for a “solid caplet” or for a particular dosage                       
                 of drug contained therein                                                                               
                        Particularly glaring is the examiner’s failure to point to a specific passage                    
                 in the reference showing a caplet having a convex surface on one end, with a                            
                 specific radius of curvature relative to the radius of the caplet.  In reviewing the                    
                 reference ourselves, we have been unable to find such a disclosure.                                     
                        Thus, the examiner has not shown that the prior art disclosed a drug-                            
                 delivery system, whether characterized as caplet or capsule, having the                                 
                 particular geometric limitations recited in the instant claims.  The examiner has                       





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007